A privately held, clinical-stage biotechnology company developing first-in-class antibody therapeutics for cancer, autoimmune, and other serious diseases
drenbio.comFoster City, CABiotechFounded 2019
3 sources · checked 1 time, last 41m ago
Sources agree on the financing amount, date, leads, participants, and headquarters. Neither source states a conventional round stage, financing total, or valuation.
1 source
Developing: it holds up against its sources so far, and firms up as more reporting lands.
The source distinguishes the $65 million round from the Company’s total capital received to date over $156 million; the latter is not a financing total for this Series B.
| Round | Amount | Announced | Lead | Buzz |
|---|---|---|---|---|
| Funding round | $350M | 2026-10-28 | Juvia Group, Lightspeed | 1 person on X · 3 outlets. #45 in Trending |
3 sources · checked 1 time, last 41m ago [ VERIFIED · CORRECTED ] read against 2 of 3 sources
Sources agree on the financing amount, date, leads, participants, and headquarters. Neither source states a conventional round stage, financing total, or valuation. | ||||
Found on X with Firecrawl search
Dren Bio is a privately held, clinical-stage biopharmaceutical company that discovers and develops first-in-class antibody therapeutics to selectively deplete pathogenic cells and other disease-causing agents for cancer, autoimmune, and other serious diseases.
Checked against 10 sources today
| Series B [ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $65M | 2022-06-14 | Aisling Capital, HBM Healthcare Investments | No recent discussion |
1 source [ DEVELOPING ] Developing: it holds up against its sources so far, and firms up as more reporting lands. read against 1 source
The source distinguishes the $65 million round from the Company’s total capital received to date over $156 million; the latter is not a financing total for this Series B. [ BUILT WITH ]·[ SEARCH ]found by Firecrawl search·[ SCRAPE ]1 page read: businesswire.com·[ JSON ]round read into a schema, with the sentence that states it·[ VERIFY ]correctedchecked against 1 source·[ BRANDING ]logo and colour from the homepage·[ AGENT ]company research by the Firecrawl agent | ||||